Table 2.
Protocols | Reference |
---|---|
0.01 μM 1,25-dihydroxyvitamin D3, 50 μM ascorbate-2-phosphate, 10 mM β-glycerophosphate | [26, 113] |
10 mM β-glycerophosphate, 0.1 mM ascorbic acid, 1 μM dexamethasone and a pulsed electromagnetic field (PEMF) | [80] |
50 μg/mL ascorbic 2 phosphate, 10−8 mM dexamethasone and 10 mM β-glycerol-phosphate and Matrigel | [92] |
3D type I collagen matrices and 10% or 12% uniaxial cyclic tensile strain at 1 Hz for 4 h/day | [93] |
Artificial extracellular matrices containing collagen and chondroitin sulfate with hydrostatic pressure (HP) | [81] |